Your browser doesn't support javascript.
loading
Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28.
Chew, Emily Y; Clemons, Traci E; Agrón, Elvira; Domalpally, Amitha; Keenan, Tiarnán D L; Vitale, Susan; Weber, Claire; Smith, Douglas C; Christen, William.
Affiliation
  • Chew EY; Division of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, Maryland.
  • Clemons TE; The EMMES Corporation, Rockville, Maryland.
  • Agrón E; Division of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, Maryland.
  • Domalpally A; Department of Ophthalmology, University of Wisconsin, Madison.
  • Keenan TDL; Division of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, Maryland.
  • Vitale S; Division of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, Maryland.
  • Weber C; Division of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, Maryland.
  • Smith DC; Division of Preventive Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Christen W; Division of Preventive Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
JAMA Ophthalmol ; 140(7): 692-698, 2022 07 01.
Article in En | MEDLINE | ID: mdl-35653117

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Fatty Acids, Omega-3 / Lung Neoplasms / Macular Degeneration Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans Language: En Journal: JAMA Ophthalmol Year: 2022 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Fatty Acids, Omega-3 / Lung Neoplasms / Macular Degeneration Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans Language: En Journal: JAMA Ophthalmol Year: 2022 Document type: Article Country of publication: United States